Prostate Cancer Treatment at Cleveland Clinic
Links shared publicly online about this topic.
- 775total visits
Prostate Cancer Treatment at Cleveland Clinic
View full resource at clevelandclinic.org
Tags: Cancer, Cancer Prevention, Prostate Cancer, Prostate, Healthcare, Men's Health, Cleveland Clinic
Most Recently Shared on October 25, 2010 at 9:49 pm By:
RT @ClevelandClinic: Prostate cancer screening test improves patient quality of life http://ow.ly/2Z6cQ Treatment guide: http://ow.ly/2Z6rC
Annual Health Fair
my.clevelandclinic.org — “enlarged prostate treatment – Glickman Urological Institute – Cleveland Clinic - leader in urology and urological treatments, kidney transplants and enlarged prostate treatment.” View full resource at my.clevelandclinic.org
Most Recently Shared on April 7, 2012 at 6:30 pm By:
Cleveland Clinic Healthcare System
Our 10th Annual Minority Men's Health Fair is Thurs, 4/26. Free screenings, health info. #ActNow http://t.co/9Uw8aLiL
Cryotherapy - minimally invasive prostate cancer treatment | Dr. Scionti
drscionti.com — “Prostate cryotherapy procedure, canidates, treatment process, advantages, side effects, insurance coverage and clinical outcomes.” View full resource at drscionti.com
Most Recently Shared on March 26, 2012 at 5:23 pm By:
Stephen Scionti, MD Urologist, Physician, Doctor, and Surgeon
Just one of the treatments I offer at Scionti Prostate Center of Boston is Cryotherpy learn more about the procudure at http://t.co/8fhqRuj9
Symposier - Germline Predictors Of Androgen Deprivation Therapy (ADT) Response In Advanced Prostate Cancer
symposier.com — “Uploaded and shared in Youtube by: mayoclinic — Dr. Manish Kohli, Associate Professor of Medical Oncology at Mayo Clinic in Rochester, MN, discusses his article appearing in the March 2012 issue of Mayo Clinic Proceedings, on the association of the TRMT11 gene and prostate cancer and identifying predictive biomarkers. This research may improve prediction of response to hormonal treatments in advanced prostate cancer patients and potentially enhance delivery of individualized medicine in future p” View full resource at symposier.com
Most Recently Shared on March 16, 2012 at 4:25 pm By:
Symposier Endocrino Health Site
Germline Predictors Of Androgen Deprivation Therapy (ADT) Response In Advanced Prostate Cancer http://t.co/MFsrkWyh
Prostate Artery Embolisation for BPH by Dr Nigel Hacking | totalhealth
totalhealth.co.uk — “Prostate Artery Embolisation is a new treatment for benign prostatic hyperplasia/hypertrophy and will be of interest to any men who have been unsuccessfully treated in the past.” View full resource at totalhealth.co.uk
Most Recently Shared on March 15, 2012 at 10:03 am By:
@TheProstateCC New and emerging treatment for Prostate Cancer by Dr Nigel Hacking totalhealth: http://t.co/4gv7T36P #hcsm #hcsmeu
Prostate cancer treatment mismatched with clinical benefit - ONA
oncologynurseadvisor.com — “Therapy has become more aggressive for men with a low likelihood of clinical benefit, but not for men with a high likelihood of clinical benefit.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 13, 2012 at 1:45 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Prostate cancer treatment mismatched with clinical benefit http://t.co/slvSftH2 #ProstateCancer #Oncology
Arch Intern Med -- The Relationship Between Clinical Benefit and Receipt of Curative Therapy for Prostate Cancer, February 27, 2012, Raldow et al. 172 (4): 362
archinte.ama-assn.org — “Archives of Internal Medicine, a bi-monthly professional medical journal published by the American Medical Association, publishes original peer-reviewed research articles on internal medicine topics” View full resource at archinte.ama-assn.org
Most Recently Shared on March 5, 2012 at 10:07 pm By:
ArchInternalMedicine Medical Journal
#prostatecancer treatment over time: more aggressive treatment despite lower life expectancy http://t.co/GVVFC5Sa #archinternmed
AIM: Prostate cancer therapy trends moving in wrong direction
healthimaging.com — “Men with localized prostate cancer may not be receiving curative therapy (CTx) in accordance with potential clinical benefit, as patients with a low likelihood to benefit have received increasingly aggressive treatment in recent years while patients in groups that are likely to benefit from CTx have not seen comparable increases in treatment, according to a research letter published in the Feb. 27 issue of Archives of Internal Medicine.” View full resource at healthimaging.com
Most Recently Shared on February 27, 2012 at 11:33 pm By:
Health Imaging & IT Health Magazine
AIM: Prostate cancer therapy trends moving in wrong direction http://t.co/zPzduZYD
Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer
news-medical.net — “Tiltan Pharma Ltd. today announced that it has commenced a Phase 2 clinical trial of its anti-angiogenic product TL-118 for the treatment of pancreatic cancer.” View full resource at news-medical.net
Most Recently Shared on February 13, 2012 at 4:10 pm By:
Prostate Cancer: Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer: Tiltan Pharma Ltd. today ... http://t.co/91quBbZd
Living Longer with Immunotherapy for Advanced Prostate Cancer - Patient Power
patientpower.info — “In this video interview from the ASCO (American Society of Clinical Oncology) Genitourinary Cancers Symposium, Dr. Chadi Nabhan explores the phase III results of the IMPACT study. The study results suggest that treating advanced prostate cancer with active immunotherapy may increase survival even longer that previously documented. He also discusses promising research and treatments in development, and why he feels this is an “exciting time for men with prostate cancer.”” View full resource at patientpower.info
Most Recently Shared on February 8, 2012 at 10:43 pm By:
Living Longer with Immunotherapy for Advanced Prostate Cancer - Patient Power - http://t.co/FJsAUQl8
Abstracts - ASCO
asco.org — “Abstracts - ASCO - The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide, and lead the fight for more effective cancer treatments, increased funding for clinical and translational research, and, ultimately, cures for the many different cancers that strike millions of people around the world every year.” View full resource at asco.org
Most Recently Shared on February 4, 2012 at 11:45 pm By:
Arnon Krongrad, MD is a board certified urologist with special interest in laparoscopic prostate surgery; he is the surgeon who introduced the minimally invasive technique into the United States in 1999. Dr. Krongrad has a practice focused on localized prostate cancer and severe, chronic prostatitis. Some of his papers are listed on Academia." /> Arnon Krongrad, MD Surgeon, Urologist, Physician, Active Health Library, and Doctor
Protons for prostates: finally, data and protons don't look so good. http://t.co/iHeddan2
New Vaccine Approach Discovered For The Treatment Of Cancer
medicalnewstoday.com — “Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental” View full resource at medicalnewstoday.com
Most Recently Shared on January 30, 2012 at 9:06 am By:
New Vaccine Approach Discovered For The Treatment Of Cancer http://t.co/ymfvBvd3 #prostate
Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer
news-medical.net — “Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.” View full resource at news-medical.net
Most Recently Shared on January 5, 2012 at 10:28 am By:
Meningitis News: Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer: Viamet Pharma... http://t.co/RLiZ4zPY
Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab
medicalnewstoday.com — “An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The stud” View full resource at medicalnewstoday.com
Most Recently Shared on November 16, 2011 at 10:06 am By:
Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab http://t.co/1LkhIR3M #prostate
Chinese herb in prostate cancer trial - UPI.com
upi.com — “An ancient Chinese herbal remedy is being tested in a clinical trial as a prostate cancer treatment drug, U.S. researchers say.” View full resource at upi.com
Most Recently Shared on November 1, 2011 at 9:38 am By:
Chinese herb in prostate cancer trial: SAN ANTONIO, Nov. 1 (UPI) -- An ancient Chinese herbal remedy is being te... http://t.co/XW1jVgIL
AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment
news-medical.net — “AgonOx today announced that it has entered into an exclusive global partnership with MedImmune, the global biologics arm of AstraZeneca, to develop agonists using its OX40 platform. MedImmune will lead further preclinical and clinical studies of this tumor-specific T-cell immunity stimulator for the potential treatment of cancer.” View full resource at news-medical.net
Most Recently Shared on October 31, 2011 at 6:44 pm By:
Prostate Cancer: AgonOx, MedImmune partner to advance OX40 agonist programs for cancer treatment: AgonOx today a... http://t.co/GLEm5Kca
Advertisement
